Insmed | INSM - EPS Earnings Per Share


Insmed reported $-0.76 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 -0.61 -1.75 Oct/22
FY2026Q2 Jun/2026 -0.75 -1.70 Jul/30
FY2026Q1 Mar/2026 -0.76 -0.99 -1.42 May/07
FY2025Q4 Dec/2025 -1.54 -1.28 -1.32 Feb/19
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30




Eps Change Date
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
DBV Technologies USD -0.55 0.31 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026